Drug Information Association Logo

Safety and Social Media: Is this the Question or the Answer

| Online

« Back to Listing


Continuing Education credit or Certificate Program units are not available for Archived Webinars.

Social media has the potential to advance health literacy, safety, and transparency in the pharmaceutical industry, although potential pitfalls and liabilities have inhibited the industry’s participation. In spite of these challenges and fears, there are compelling facts that the time to join the conversation is now. Eight in ten internet users look online for health information, making it the third most popular online activity among those included in a recent Pew Internet Project survey. This digitization of healthcare creates scenarios that need to be addressed, understood and challenged.

The panelists on this webinar will discuss the benefits and risks of social media. They will answer:

  • Can social media improve drug safety?
  • What examples do we have of social media being used to improve drug safety?
  • Is it possible for pharma to participate or must this be done by 'outsiders', and if so, what are the implications for pharma?
  • What must change for us to realize the value of social media in drug safety?
  • How can we make it happen?

This Archived Webinar is available for purchase through September 11, 2014.


Who Should Attend 

Professionals with intermediate to advanced knowledge of, and experience in, clinical safety and who are involved in:

  • Pharmacovigilance
  • Drug Safety
  • Risk Management
  • Medical Product Safety Assessment
  • Regulatory Affairs
  • Clinical Research
  • Data Analysis
  • Pharmacoepidemiology
  • Medical Information
  • Health Outcomes

Learning Objectives 

At the conclusion of this webinar, participants should be able to:

  • Identify ways social media can advance health literacy, safety, and transparency in the pharmaceutical industry.
  • Discuss ways social medial can improve drug safety.

Contact Information 

Printable Registration Form

Registration Questions
Toll Free 1.888.257.6457
Phone +1.215.442.6100
Fax +1.215.442.6199
Monday-Friday 8:30 AM to 8:00 PM ET

Archived Webinar Information
Carolyn Callahan
Phone +1.215.442.6194
Fax +1.215.442.6199

Technical Requirements 

Follow this link for minimum system requirements.


Previous Next


Day 1 Thursday, Sep 12, 2013

  • 11:00AM - 11:59PM

    Safety and Social Media: Is this the Question or the Answer


    • Introduction
      Elizabeth E. Garrard, PharmD
      Senior Director, Safety Risk Management
      United Therapeutics Corporation, United States
    • Safety and Social Media: a Unique Perspective
      Linda J. Scarazzini, MD
      Vice President of Medical Safety Evaluation
      AbbVie, United States
    • Why A Lack of Vision Will Keep Us from Using Social Media to Improve Safety
      Michael A. Ibara, PharmD
      Head of Business Development Coordination and Innovation, WW Safety & Regulatory
      Pfizer Inc, United States
    • A Data Geek’s Perspective on Social Media and Technology in Drug Safety
      Brian M. Overstreet
      AdverseEvents Inc., United States
    • Safety and Social Media
      Nabarun Dasgupta, PhD, MPH
      President; Research Scientist, UNC at Chapel Hill
      Epidemico, Inc. , United States

Registration Fees 

Other Fees

Government (Full Time) Individual
Charitable Nonprofit/Academia Individual
Group Site
Group Plus


Member Industry Individual


NonMember Industry Individual
Group Discounts

  • Group site registration is a license for ONE internet login allowing multiple viewers from one location.
  • Group Plus is a license for up to FIVE internet logins allowing one or more viewers at each login location.

No refunds will be provided in the event of a participant’s cancellation since all costs for this webinar have been prepaid by DIA. DIA reserves the right to modify or cancel programs and/or substitute presenters or panelists. DIA is not responsible for failure to deliver programs due to circumstances beyond its control.

Participants with Disabilities Reasonable accommodations will be made available to persons with disabilities who attend an educational activity. Contact the DIA office in writing at least 15 days prior to event to indicate your needs.

Register Online

Unless otherwise disclosed, the statements made by speakers represent their own opinions and not necessarily those of the organization they represent, or that of the Drug Information Association. Speakers, agenda and CE information are subject to change without notice. Recording of any DIA educational material in any type of media is prohibited without prior written consent from DIA.

« Back to Listing Back To Top